关于Certara
Certara 利用生物模拟软件、技术和服务加速药物研发,从而改变传统的药物研发方式。其客户包括超 2,600 家生物制药公司、学术机构和来自 70 个国家的监管机构。Visit us at www.certara.com.
Investor Relations Contact
David Deuchler
Gilmartin Group
[email protected]
媒体联系人:
Alyssa Horowitz
[email protected]
Home / Press Release / Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
Radnor, Pa. — 2026 年 1 月 29 日 — Certara, Inc. (纳斯达克股票代码:CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2025 before market open on Thursday, February 26th, 2026. Company management will host a conference call to discuss financial results at 8:30AM ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.
A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
Certara 利用生物模拟软件、技术和服务加速药物研发,从而改变传统的药物研发方式。其客户包括超 2,600 家生物制药公司、学术机构和来自 70 个国家的监管机构。Visit us at www.certara.com.
David Deuchler
Gilmartin Group
[email protected]
Alyssa Horowitz
[email protected]
